Rachel Levine, Homeopath and CCHM alumnus, contributed this blog on her experience at the recent Homeonet Conference:
The Homeonet Research Forum in Toronto November 2, 2012 offered wonderful insight into current homeopathic research. I had the opportunity to give a talk on the Homeopathic Treatment of Depression in Intersex Individuals.
As most of the talks rested heavily on data, my presentation was steeped in Hahnemannian conducted cases; one Klinefelter Sydrome case, as well as a Polycystic Ovarian Syndrome case was presented. Both cases offered remarkable results. Each case was managed with subsequent intercurrent remedies and there was a complete reduction in all secondary symptoms.
Polycystic Ovarian Syndrome (PCOS) occurs in 1 in 15 women. Klinefelter Syndrome (KS) occurs in 1 in 1000 births and is considered one of the most common chromosomal variations. Intersex individuals are born with possible anatomical and physiological sexual differences, resulting in many different intersex variations. Intersex best describes genital, gonadal and chromosomal variants, which are neither completely ‘male’ nor ‘female.’ Depression often occurs in these individuals; the significant hormone imbalance is the primary dynamic shift and the social affect is the second.
To accompany this talk, I put together a poster presentation which was A Critical Examination of the Use of Homeopathy as a Treatment Option for Polycystic Ovarian Syndrome. The objective of this review was to investigate the potential use of homeopathy in the treatment of PCOS and explore methodological approaches used in studies assessing the interventions for PCOS that may be applied to future homeopathic clinical trials for this condition. Countless allopathic studies have been conducted with PCOS; two were identified as being relevant to the design of future homeopathic trials.